###begin article-title 0
Multiple Endocrine Neoplasia Type 1 (MEN1) as a Cancer Predisposition Syndrome: Clues into the Mechanisms of MEN1-related Carcinogenesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way.
###end p 1
###begin p 2
Cancer is a major public health problem in the United States and around the world with millions of new cases diagnosed each year. While most of the cancers occur sporadically, a number of familial cancer predisposition syndromes have been identified in recent years. Cancer susceptibility syndromes are responsible for an estimated 5 to 10 percent of all cancer cases. Genes responsible for hereditary cancers are often also mutated in sporadic cancers. Studies of cellular functions of cancer susceptibility genes have made an invaluable contribution to our understanding of tumorigenesis.
###end p 2
###begin p 3
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer predisposition syndrome, the gene for which encodes a nuclear protein: menin. The biochemical function of this protein is largely unknown, but several studies have shown a role in transcriptional modulation through interaction with histone deacetylases and histone methyltransferases. Tumors in MEN1 arise through a two-hit mechanism, suggesting that menin either negatively regulates cell growth or participates in maintenance of genomic integrity.
###end p 3
###begin p 4
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
In this work, we provide a general overview of the hereditary cancer syndromes with both dominant and recessive mode of inheritance. We then discuss recent advances in understanding the biological role of MEN1 gene and the mechanisms by which inactivation of MEN1 may lead to neoplastic transformation.
###end p 4
###begin title 5
Hereditary cancer predisposition syndromes
###end title 5
###begin p 6
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 984 985 984 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
Despite the complexity of cancer as a disease, there are some common features shared by all cancer cells that distinguish them from their normal counterparts. They are immortal and have a high proliferative potential. They no longer require external growth signals to activate the proliferation program and are insensitive to growth inhibitory signals. They have developed mechanisms for evading senescence and programmed cell death, or apoptosis. In order to ensure tumor growth, the cells of solid tumors must promote the formation of new blood vessels for oxygen and nutrient supply. And, finally, malignant cells fail to exhibit normal cell-cell interactions, which results in their ability to invade and to metastasize and grow in an abnormal cellular environment [1]. The acquisition of these qualities is not a single event but rather the result of an accumulation of multiple genetic alterations leading to escape from normal control of growth regulation and differentiation [2].
###end p 6
###begin p 7
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
Genes with very diverse cellular functions have been implicated in carcinogenesis. This includes genes involved in intracellular signaling cascades, cell cycle control, cell differentiation, apoptosis, protein synthesis and degradation, organization of cytoskeleton, cell migration, cell-cell interaction, regulation of transcription, chromatin remodeling, and DNA damage sensing and repair [3-5]. Understanding how the disruption of these cellular processes leads to tumor formation is the key to rational development of effective cancer therapies.
###end p 7
###begin p 8
Because the development of cancer is a multi-step process, it may take years between the occurrence of the first genetic lesion and the actual formation of malignant neoplasm. Thus, the incidence of cancer increases with age. In rare cases, however, individuals inherit a mutant allele of a cancer predisposition gene, which increases the mutation rate and promotes the development of cancer. Thus, individuals with cancer predisposition syndromes have both a greater risk of developing cancer and an average earlier age of onset compared to the general population.
###end p 8
###begin p 9
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">7</xref>
###xml 826 827 826 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">7</xref>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
In 1971, Knudson proposed his famous "two-hit" hypothesis [6]. By observing patients with familial and sporadic retinoblastoma, he suggested that individuals with familial cases inherited the first genetic lesion, or "hit," and that they only needed to acquire one more hit to develop cancer. These patients developed retinoblastoma at an earlier age than individuals with sporadic tumors who needed to acquire two somatic hits in the same cell. This hypothesis was confirmed with the discovery of the retinoblastoma (RB1) gene in 1986 [7]. Indeed, individuals with familial retinoblastoma inherited a germline mutation in one allele of the RB1 gene with the remaining wild type allele being lost in tumors, often through a process involving large deletions with loss of heterozygosity (LOH) for surrounding polymorphic loci [7].
###end p 9
###begin p 10
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
Since the discovery of RB1, multiple tumor-predisposition genes have been identified by the study of familial cancer syndromes. It is estimated that 5 to 10 percent of all cancers develop in individuals who have inherited a mutation conferring cancer susceptibility [8]. Analysis of the genes responsible for hereditary cancer predisposition and the pathways in which they act has been critically important in providing insight into cancer formation, because the same genes that are affected in cancer-predisposition syndromes are often responsible for the majority of somatic cancer cases as well. For example, germline mutations in the APC gene account for less than one percent of all colorectal cancers, but APC is also inactivated in nearly all sporadic colon cancers [2].
###end p 10
###begin p 11
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">11</xref>
More than 50 cancer predisposition syndromes have been identified to date [8,9] with both dominant and recessive modes of inheritance (Table 1). Activating mutations in oncogenes occur only in a few cases, such as RET in multiple endocrine neoplasia type 2 (MEN2) [10] and MET in familial papillary renal carcinoma [11]. Activated oncogenes function dominantly in the cell, and mutation of the second allele is not required. Most of the dominantly inherited cancer syndromes, however, have an inactivating mutation in a tumor suppressor, and disease formation follows the two-hit rule. The first hit is a germline mutation that exists in every cell of the body. Somatic inactivation of the second allele of the same locus in certain tissues may initiate neoplastic transformation. Thus, cancer predisposition syndromes often have dominant mode of inheritance at the level of the organism, but at the cellular level they are recessive because inactivation of both copies of the gene is required for cancer formation.
###end p 11
###begin p 12
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 1696 1698 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 86 97 <span type="species:ncbi:111938">gatekeepers</span>
###xml 114 125 <span type="species:ncbi:111938">Gatekeepers</span>
###xml 270 280 <span type="species:ncbi:111938">gatekeeper</span>
###xml 345 356 <span type="species:ncbi:111938">gatekeepers</span>
###xml 635 646 <span type="species:ncbi:111938">gatekeepers</span>
###xml 901 911 <span type="species:ncbi:111938">gatekeeper</span>
###xml 967 978 <span type="species:ncbi:111938">gatekeepers</span>
###xml 1139 1144 <span type="species:ncbi:9606">human</span>
###xml 1191 1199 <span type="species:ncbi:9606">patients</span>
###xml 1582 1593 <span type="species:ncbi:111938">gatekeepers</span>
Genes whose inactivation leads to tumorigenesis are divided into two distinct groups: gatekeepers and caretakers. Gatekeepers are usually "classical" tumor suppressors that directly regulate cell growth, differentiation, and death in certain tissues. Dysregulation of a gatekeeper is necessary to initiate neoplastic transformation. Examples of gatekeepers include APC for colon epithelia, RB1 for retinal epithelia, NF1 for Schwann cells, and VHL for kidney cells [2,12]. Inactivation of both homologs of these genes is found both in hereditary forms of cancer and in the majority of sporadic cancers of the same type. In contrast to gatekeepers, caretaker genes do not directly regulate cell growth. Caretaker genes are involved in DNA repair and maintenance of genomic integrity. Inactivation of a caretaker does not directly promote tumor formation but facilitates the development of mutations in gatekeeper genes and other cancer-related genes. Caretakers, like gatekeepers, may be tissue-specific, but mutation in a caretaker is neither necessary nor sufficient for the development of cancer. Mutations in some caretaker genes cause human cancer by the two-hit mechanism. For example, patients with familial breast cancer syndromes inherit one mutant copy of BRCA1 or 2, and LOH for the second allele is found in tumors of breast and ovary [13-16]. Similarly, in hereditary non-polyposis colorectal cancer (HNPCC), one mutant copy of mismatch repair genes such as MLH1, MSH2, or MSH6 is inherited, and the wild type allele is lost in tumors of the colon [17]. However, unlike gatekeepers, mutations in caretakers are uncommon in sporadic tumors of the types seen in the hereditary disease [18].
###end p 12
###begin p 13
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
A number of human cancer predisposition syndromes have a recessive mode of inheritance (Table 1). These syndromes are also called genetic instability syndromes, because one of the hallmarks of these diseases is chromosomal instability and hypersensitivity to various DNA damaging insults. The genes mutated in these diseases, such as ATM, Fanconi anemia complementation group, NBS1, Xeroderma pigmentosum-associated genes (XPA, XPC, etc.), BLM, and RECQL4, function in DNA damage sensing or repair [4,8,9] and can be classified as caretakers by analogy with the BRCA and HNPCC genes.
###end p 13
###begin p 14
###xml 371 376 <span type="species:ncbi:9606">human</span>
 Since the identification of the first cancer predisposition gene (RB1) in 1986, tremendous advances have been made in understanding the function of multiple genes implicated in both sporadic and hereditary cancers. However, the mechanism of action of many more recently identified genes is not well understood. Further studies are necessary to provide new insights into human neoplasia and improve the diagnosis and treatment of both sporadic and hereditary cancers.
###end p 14
###begin title 15
Multiple endocrine neoplasia type 1 (MEN1)
###end title 15
###begin p 16
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant cancer predisposition syndrome characterized by parathyroid, pancreatic islet, and pituitary tumors as well as other neoplasms such as gastrinomas, carcinoids, lipomas, angiofibromas, angiomyolipomas and thyroid tumors [19]. Clinical manifestations depend on the affected organ. Most MEN1-associated tumors are not metastatic but create clinical effects by overproduction of hormones such as insulin, glucagon, prolactin, parathyroid hormone, gastrin, growth hormone, or adrenocorticotropic hormone [19,20]. The most common manifestation of the disease is parathyroid adenoma, with penetrance reaching almost 100 percent by the age of 50 [19]. Major causes of morbidity and mortality in MEN1 are gastrinomas and foregut carcinoids, which are often highly metastatic [19]. The estimated prevalence of MEN1 is one in 30,000 [21].
###end p 16
###begin p 17
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">22</xref>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R25">25</xref>
###xml 801 805 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">28</xref>
###xml 775 780 <span type="species:ncbi:9606">human</span>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
MEN1 was localized to chromosome 11q13 by linkage analysis, and the gene was later identified by positional cloning [23,24]. Tumors in MEN1 arise through the two-hit mechanism with germline mutation in one copy of the gene and somatic loss of the normal allele [22]. Germline mutations in MEN1 are mainly nonsense or frameshift and are presumed to cause inactivation of the gene. The transcript of the MEN1 gene contains an open reading frame predicted to encode 610 amino acid proteins. Analysis of the sequence of the protein menin showed two nuclear localization signals near the carboxyl terminus but has not provided any other clues to its function. Immunocytochemical studies of interphase somatic cells show that the protein is located in the nucleus [25]. Studies in human and mouse show that MEN1 is expressed widely in adult and fetal tissues with high levels in the CNS, lung, liver, kidney, testis, and fetal thymus [23,26-28].
###end p 17
###begin p 18
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R30">30</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">31</xref>
###xml 952 954 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R32">32</xref>
###xml 1084 1086 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 1126 1128 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 1283 1298 1279 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila MEN1</italic>
###xml 1314 1321 1310 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1337 1341 1333 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 1422 1432 1418 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1652 1654 1648 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
###xml 1655 1657 1651 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 51 56 <span type="species:ncbi:4932">yeast</span>
###xml 1283 1293 <span type="species:ncbi:7227">Drosophila</span>
###xml 1422 1432 <span type="species:ncbi:7227">Drosophila</span>
Among the earliest studies of menin function was a yeast two-hybrid analysis showing interaction between menin and JunD, a component of the AP-1 transcription factor [29]. Studies in mammalian tissue culture systems showed that the N-terminal half of menin could inhibit JunD-mediated transcription. Menin did not bind to other AP-1 components such as c-Jun, JunB, or four members of the Fos family. Further investigation of menin's involvement in JNK and other MAP kinase signaling cascades revealed that overexpression of MEN1 in some cell lines inhibited ERK-mediated phosphorylation of JunD and Elk1 and JNK-dependent phosphorylation of JunD and c-Jun [30]. In addition, overexpression of menin in CHO-IR cells suppressed insulin-induced activation of AP-1 and transcriptional induction of c-Fos [31]. Similarly, menin was shown to bind to and inhibit transcriptional activation by several members of the NF-kappaB family of transcription factors [32]. Binding of menin to SMAD3 appears to enhance transcriptional activation function, and loss of menin blocks TGF beta signaling [33]. The homeobox-containing protein Pem [34] has also been shown to bind menin in biochemical assays. These data suggest that menin may act as a transcriptional regulator. Our investigations of the Drosophila MEN1 homolog showed in vivo interaction of MEN1 with JNK signaling pathway components. We also found that when tethered to DNA, Drosophila menin acts as a transcriptional repressor. Menin does not have any recognizable DNA binding motifs, and data are conflicting as to whether menin can directly bind DNA and whether it binds in a sequence-specific manner [35,36].
###end p 18
###begin p 19
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R39">39</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">43</xref>
###xml 749 753 749 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 761 766 761 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4c</sup>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 119 124 <span type="species:ncbi:9606">Human</span>
Multiple lines of evidence exist to support menin's involvement in transcriptional control and chromatin modification. Human menin was found to bind and control the activity of multiple transcription factors. Menin interacts with mSin3a, a component of the Sin3/Rpd3 HDAC complex [37], and with a histone methyltransferase complex containing the trithorax family proteins MLL2 and Ash2L [38-41]. In addition, menin was found to bind to the promoter regions of several homeobox genes and to regulate their expression [38,39]. Genome-wide analysis of genomic binding sites showed menin's localization to the promoters of multiple genes [42,43]. Recently, two other transcription targets of menin were identified. Cyclin-dependent kinase inhibitors p27kip1 and p18Ink4c are downregulated in menin-deficient cells, which also exhibited increased proliferation [40]. Thus, menin may control cell proliferation through regulating transcription of genes involved in cell cycle control.
###end p 19
###begin p 20
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 721 723 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 801 803 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46">46</xref>
###xml 895 897 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">47</xref>
###xml 948 958 944 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 970 974 966 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 1042 1046 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1</italic>
###xml 1050 1060 1046 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1208 1212 1204 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1</italic>
###xml 1367 1369 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">48</xref>
###xml 1406 1416 1402 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1509 1511 1505 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R49">49</xref>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 948 958 <span type="species:ncbi:7227">Drosophila</span>
###xml 1050 1060 <span type="species:ncbi:7227">Drosophila</span>
###xml 1406 1416 <span type="species:ncbi:7227">Drosophila</span>
###xml 1564 1569 <span type="species:ncbi:9606">human</span>
That tumors in MEN1 arise through two-hit mechanism suggests that menin may act in the regulation of cell growth or in the maintenance of genomic integrity, as discussed above. Several lines of evidence suggest that menin might participate in DNA damage sensing or repair. Peripheral blood lymphocytes from MEN1 patients have an elevated frequency of chromosomal abnormalities after exposure to the cross-linking agent diepoxybutane (DEB) [44]. Menin-deficient mouse embryonic fibroblasts (MEFs) are hypersensitive to DEB [45]. Menin interacts with FANCD2, a gene that underlies the genetic instability syndrome Fanconi anemia. Moreover, this interaction is strengthened after the exposure of cells to gamma-irradiation [45]. In addition, menin was shown to interact with replication protein A (RPA) [46], a protein that binds single strand DNA and is important for several DNA repair pathways [47]. Studies from our laboratory show a role for the Drosophila homolog of MEN1 in maintenance of genomic integrity. We found that inactivation of Men1 in Drosophila results in flies that are sensitive to certain types of DNA damage, in particular to ionizing radiation and DNA cross-linking agents. In addition, Men1-deficient flies have an elevated mutation rate both at baseline and after treatment with ionizing radiation and nitrogen mustard (a cross-linking agent) [48]. Menin-deficient tissues from both Drosophila and mammals fail to undergo S-phase arrest in response to DNA damage by ionizing radiation [49]. These data suggest that tumor pathogenesis in the human disease may relate to genomic instability.
###end p 20
###begin p 21
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1<sup>-/-</sup></italic>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">51</xref>
###xml 497 500 497 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1<sup>-/-</sup></italic>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52">52</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 895 900 <span type="species:ncbi:10090">mouse</span>
 Studies also support a direct role for MEN1 in the control of cell growth and differentiation. Overexpression of menin represses the proliferation and tumorigenesis of Ras-transformed NIH3T3 cells and insulinoma cells [50]. Data are conflicting as to whether menin-deficient mouse cells have increased proliferative capacity. One study found no cell-autonomous proliferative defects in Men1-/- embryonic stem (ES) cells or embryonic fibroblasts (MEF) [51]. However, another study showed that Men1-/- MEFs have increased proliferative capacity, and reintroduction of wild type menin suppresses their growth, possibly through an interaction with activator of S-phase kinase (ASK), a component of the Cdc7/ASK kinase complex [52]. Some phenotypes seen in mouse models of MEN1 suggest a direct role in growth control. For example, tissue-specific gene inactivation in pancreatic islet cells of the mouse leads to widespread hyperplasia, consistent with a similar role for the gene postnatally [53].
###end p 21
###begin p 22
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1</italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">54</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">51</xref>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1</italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Men1</italic>
###xml 1187 1189 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 1190 1192 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">55</xref>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 721 726 <span type="species:ncbi:10090">mouse</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 1099 1103 <span type="species:ncbi:10090">mice</span>
A mouse model with targeted disruption of the Men1 gene showed that menin has an essential role in development [54]. The phenotype of heterozygotes was very similar to the human MEN1 phenotype with tumors of the parathyroid, pituitary, pancreatic islets, thyroid, and adrenal cortex. Homozygous mice died in utero. They appeared normal at E9.5 but by E11.5-12.5 were developmentally delayed and smaller than normal littermates. Virtually all fetuses were resorbed by E14.5. Morphological defects included an open neural tube, hypoplastic myocardium, and an extremely malformed liver with abnormal organization of the epithelial and hematopoietic compartments and increased apoptosis [51]. Conditional knockout of Men1 in mouse pituitary and pancreatic islets showed that both these organs were able to develop normally even if Men1 was deleted in early embryogenesis. Pancreatic islets developed beta-cell hyperplasia and later, in six- to 12-month-old mice, pancreatic islet adenomas. Insulinomas and prolactinomas developed in some animals starting at nine months. The late tumorigenesis in these mice suggests that additional somatic events are necessary to promote cancer formation [53,55].
###end p 22
###begin p 23
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
Two studies suggested a function of menin related to telomeres. Investigations in our laboratory [56] showed that menin localizes to telomeres during meiotic prophase in mouse spermatocytes. Menin foci were seen only at this location and not in other regions of meiotic cells. The foci were apparent as soon as axial elements began to form, and signals increased in intensity throughout prophase. However, menin did not co-localize with telomeric proteins, such as TRF2, in somatic cells at any stage of the cell cycle. Furthermore, telomeres of MEN1-related tumors were no different in length than telomeres of histologically similar sporadic tumors arising without MEN1 mutations. Overexpression of menin did not influence telomerase activity as assessed by TRAP assays. Another study, which systematically examined the effects of tumor suppressor genes on telomere maintenance, suggested that loss of menin function might stimulate telomerase (hTERT) expression [57] and that menin might be involved in tumorigenesis through this mechanism.
###end p 23
###begin p 24
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">58</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">59</xref>
Menin has also been found to associate with several cytoskeleton components. Menin's interaction with the intermediate filament proteins GFAP and vimentin was suggested to control its nuclear import [58]. Another cytoskeletal interactor of menin is nonmuscle myosin II-A heavy chain protein, which was found to co-localize with menin at the cleavage furrow during cytokinesis [59].
###end p 24
###begin title 25
Conclusions and outlook
###end title 25
###begin p 26
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 471 473 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R60">60</xref>
###xml 474 476 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 607 611 603 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 620 625 616 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4c</sup>
###xml 679 681 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
###xml 682 684 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R60">60</xref>
###xml 685 687 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 688 690 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
In the 10 years since the MEN1 gene was first cloned, a wealth of information concerning its possible function in tumorigenesis has been obtained. The accumulated genetic and biochemical data show that menin has multiple binding partners in a cell. By virtue of interacting with several transcription factors, menin is proposed to be involved in signaling pathways such as JNK, MAPK, TGF beta, and NF-kappaB; all of which have a well-documented role in cancer formation [60-63]. At the same time, through its role in chromatin modification, menin has been shown to affect the expression of c-Fos, hTERT, p27kip1, and p18Ink4c, which are also linked to neoplastic transformation [57,60,64,65]. On the cellular level, menin has been shown to regulate cell cycle progression and genomic integrity, both of which are often associated with a cancer phenotype.
###end p 26
###begin p 27
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R66">66</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R49">49</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
The multiple functions of MEN1 are not altogether unconnected. As a regulator of transcription, menin could control the expression of multiple factors involved in cell cycle regulation and the DNA damage response (see the examples above). The transcription regulation is likely achieved through menin's function in chromatin modification. At the same time, there is a wealth of evidence connecting the modification of chromatin with the maintenance of genome integrity [66]. Finally, the possibilities of MEN1's involvement in cell cycle regulation and genome maintenance are not mutually exclusive. MEN1 was shown to regulate proper S-phase arrest in response to exogenous DNA damage [49]. Similar regulation is necessary in the cell as endogenous DNA damage occurs every cell cycle during DNA replication [67].
###end p 27
###begin p 28
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1&#8217;s</italic>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 907 911 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEN1</italic>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
Taken together, the accumulated knowledge of MEN1's potential functions and cellular partners suggests several possible mechanisms of its involvement in cancer formation. The key question is which of these functions or interactions play critical role in cancer development. One possible way to address this challenging problem is systematic investigation of tumors obtained from Men1 heterozygous mice as well as from MEN1 patients. One such study generated p18(-/-)Men1(+/-) and p27(-/-)Men1(+/-) mice and found that p18 functionally collaborates with MEN1 in suppressing lung and neuroendocrine tumors [64,65]. Another important question is whether menin aids in the maintenance of genome integrity by regulating the cell cycle or by serving as a structural component of DNA repair machinery. To this end, analysis of mutational spectra could point to a DNA repair step(s) most deficient in cells lacking MEN1. Careful examination of interactions between menin and known DNA repair proteins is also necessary. Addressing these issues is of key importance for the understanding of MEN1-related carcinogenesis and for the development of effective therapeutic approaches.
###end p 28
###begin article-title 29
The hallmarks of cancer
###end article-title 29
###begin article-title 30
Lessons from hereditary colorectal cancer
###end article-title 30
###begin article-title 31
Principles of tumor suppression
###end article-title 31
###begin article-title 32
Histone deacetylases, transcriptional control, and cancer
###end article-title 32
###begin article-title 33
Mutation and cancer: statistical study of retinoblastoma
###end article-title 33
###begin article-title 34
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
###end article-title 34
###begin article-title 35
Hereditary cancer predisposition syndromes
###end article-title 35
###begin article-title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cancer syndromes: clues to the origin and nature of cancer
###end article-title 36
###begin article-title 37
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
###end article-title 37
###begin article-title 38
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
###end article-title 38
###begin article-title 39
###xml 18 23 <span type="species:ncbi:9606">human</span>
Antioncogenes and human cancer
###end article-title 39
###begin article-title 40
The genetics of familial breast cancer
###end article-title 40
###begin article-title 41
BRCA2 mutations in primary breast and ovarian cancers
###end article-title 41
###begin article-title 42
Mutation analysis in the BRCA2 gene in primary breast cancers
###end article-title 42
###begin article-title 43
Low incidence of BRCA2 mutations in breast carcinoma and other cancers
###end article-title 43
###begin article-title 44
Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers
###end article-title 44
###begin article-title 45
###xml 29 40 <span type="species:ncbi:111938">Gatekeepers</span>
Cancer-susceptibility genes. Gatekeepers and caretakers
###end article-title 45
###begin article-title 46
Multiple endocrine neoplasia type 1: new clinical and basic findings
###end article-title 46
###begin article-title 47
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
###end article-title 47
###begin article-title 48
Molecular pathology of the MEN1 gene
###end article-title 48
###begin article-title 49
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
###end article-title 49
###begin article-title 50
Positional cloning of the gene for multiple endocrine neoplasia-type 1
###end article-title 50
###begin article-title 51
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1
###end article-title 51
###begin article-title 52
Menin, the product of the MEN1 gene, is a nuclear protein
###end article-title 52
###begin article-title 53
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1
###end article-title 53
###begin article-title 54
###xml 70 76 <span type="species:ncbi:10090">murine</span>
Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene
###end article-title 54
###begin article-title 55
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Characterization of the mouse Men1 gene and its expression during development
###end article-title 55
###begin article-title 56
Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
###end article-title 56
###begin article-title 57
###xml 16 19 <span type="species:ncbi:9860">Elk</span>
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation
###end article-title 57
###begin article-title 58
Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction
###end article-title 58
###begin article-title 59
The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation
###end article-title 59
###begin article-title 60
Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling
###end article-title 60
###begin article-title 61
Menin interacts directly with the homeobox-containing protein Pem
###end article-title 61
###begin article-title 62
Functional studies of the MEN1 gene
###end article-title 62
###begin article-title 63
Direct binding of DNA by tumor suppressor menin
###end article-title 63
###begin article-title 64
Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex
###end article-title 64
###begin article-title 65
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
###end article-title 65
###begin article-title 66
Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus
###end article-title 66
###begin article-title 67
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
###end article-title 67
###begin article-title 68
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
###end article-title 68
###begin article-title 69
Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis
###end article-title 69
###begin article-title 70
Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation
###end article-title 70
###begin article-title 71
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1
###end article-title 71
###begin article-title 72
Menin associates with FANCD2, a protein involved in repair of DNA damage
###end article-title 72
###begin article-title 73
The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene
###end article-title 73
###begin article-title 74
Replication protein A phosphorylation and the cellular response to DNA damage
###end article-title 74
###begin article-title 75
###xml 21 31 <span type="species:ncbi:7227">Drosophila</span>
Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1
###end article-title 75
###begin article-title 76
Multiple Endocrine Neoplasia Type 1 Interacts with Forkhead Transcription Factor CHES1 in DNA Damage Response
###end article-title 76
###begin article-title 77
Stable overexpression of MEN1 suppresses tumorigenicity of RAS
###end article-title 77
###begin article-title 78
Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs
###end article-title 78
###begin article-title 79
Functional interaction between tumor suppressor menin and activator of S-phase kinase
###end article-title 79
###begin article-title 80
Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues
###end article-title 80
###begin article-title 81
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
###end article-title 81
###begin article-title 82
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Of mice and MEN1: Insulinomas in a conditional mouse knockout
###end article-title 82
###begin article-title 83
MEN1 tumor-suppressor protein localizes to telomeres during meiosis
###end article-title 83
###begin article-title 84
Multiple tumor suppressor pathways negatively regulate telomerase
###end article-title 84
###begin article-title 85
Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity
###end article-title 85
###begin article-title 86
Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain
###end article-title 86
###begin article-title 87
JNK regulation of oncogenesis
###end article-title 87
###begin article-title 88
Signaling through RAS-RAF-MEK-ERK: from basics to bedside
###end article-title 88
###begin article-title 89
Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling
###end article-title 89
###begin article-title 90
NF-kappaB: linking inflammation and immunity to cancer development and progression
###end article-title 90
###begin article-title 91
p18Ink4c Collaborates with Men1 to Constrain Lung Stem Cell Expansion and Suppress Non-Small-Cell Lung Cancers
###end article-title 91
###begin article-title 92
p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors
###end article-title 92
###begin article-title 93
Chromatin modifications in DNA repair
###end article-title 93
###begin article-title 94
Mechanism of homologous recombination: mediators and helicases take on regulatory functions
###end article-title 94
###begin article-title 95
Alternative splicing and mutation status of CHEK2 in stage III breast cancer
###end article-title 95
###begin title 96
Abbreviations
###end title 96
###begin p 97
Multiple endocrine neoplasia type 1
###end p 97
###begin p 98
Retinoblastoma
###end p 98
###begin p 99
Loss of heterozygosity
###end p 99
###begin p 100
Diepoxybutane
###end p 100
###begin p 101
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse embryonic fibroblasts
###end p 101
###begin p 102
Replication protein A
###end p 102
###begin p 103
Embryonic stem
###end p 103
###begin title 104
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Familial cancer syndromes and cancer predisposition genes [8-9]
###end title 104
###begin p 105
Abbreviations: GAP - GTPase-activating protein; MSN - mut S homolog; MLH - mut L homolog; PMS - postmeiotic segregation; HGF - hepatocyte growth factor; BRCA - breast cancer associated; PTEN - phosphatase and tensin homolog.
###end p 105

